-+ 0.00%
-+ 0.00%
-+ 0.00%

bioAffinity sells warrants in private placement for up to 980,072 shares

PUBT·10/08/2026 16:09:06
bioAffinity sells warrants in private placement for up to 980,072 shares
  • bioAffinity Technologies priced a concurrent private placement of warrants covering 980,072 common shares at a USD 6.122 exercise price.
  • Warrants become exercisable following stockholder approval; expiration set for five years from the approval date.
  • Transaction paired with a registered direct sale priced at-the-market; gross proceeds expected to total about USD 4 million.
  • Closing targeted for about Oct. 9, 2026, subject to customary conditions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202610081207BIZWIRE_USPR_____20261008_BW434843) on October 08, 2026, and is solely responsible for the information contained therein.